Renal Ventures Management, LLC said they would begin remote monitoring a selection of their dialysis patients using Telehealth Solutions from Authentidate Holding Corp. The pilot program will be conducted in the Dallas region, and if successful in decreasing hospitalizations and mortality, may roll out company wide.
Chief Medical Officer George R. Aronoff, MD, told NN&I that AuthentiDate will provide Android tablets that RVM will place with incident dialysis patients for 120 days. Each tablet will be loaded with Authentidate’s remote patient management software. Each dialysis patient in the program will be enrolled into a specific disease management protocol that will allow case managers to direct patient care.
“Depending on their co-morbidities, patients may also be supplied with a glucometer, weight scale, BP cuff and oximeter that will record results back to the tablet via Bluetooth and then to a secure clinical portal website hosted by AuthentiDate,” Aronoff told NN&I. “Our case managers and physicians then will access patient information from their PCs by logging on to the clinical portal. The case managers will also be able to interact with patients utilizing a camera on the tablets, if needed. Using remote patient management, we will be able to interact with these patients daily.
“We chose incident patients because, according to USRDS data, they have very high hospitalization and mortality rates.”
Aronoff said they are also considering using the data that they collect to feed advanced decision support tools using predictive analytics to determine who among incident patients are the most at risk for hospitalizations and other adverse events.
RVM implemented the Coaching for Actions, Results, and Empowerment (RVCARE) program in 2010 to improve dialysis-related outcomes for incident patients. Read more about the program and its strategies.